Alight to Participate in Upcoming Investor ConferencesMar 6, 2026 1:00 PM Eastern Standard Time# Alight to Participate in Upcoming Investor ConferencesShare---CHICAGO--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading provider of health, wealth, leave and point solutions, today announced that its Chief Executive Officer, Rohit Verma, will conduct one-on-one meetings and fireside chats at the upcoming investor conferences:Bank of America Securities Information and Business Services Conference- One-on-one ...

SESSIONS GOING INTO THIS. WTI AT 86, BRENT AT 89. HERE IS MICHAEL MCKEE.MICHAEL: CHRIS WALLER WILL HAVE A HEART ATTACK NOW. 92,000 JOBS LOST DURING THE MONTH. LAST MONTH'S 100 30 THOUSAND REVISED DOWN TO 126 THOUSAND.NOT A MAJOR REVISION DOWN BUT A LOSS OF 92,000 JOBS. THERE WILL BE SOME WEATHER INVOLVED IN THAT. WE WILL CHECK ON THAT IN THE SECOND.THE TOTAL PAYROLL REVISION OVER TWO MONTHS IS -69,000. YOU HAVE TO ADD THOSE TWO THINGS TOGETHER. PRIVATE PAYROLL IS DOWN 86 THOUSAND, MANUFACTURING PAYROLL IS D ...

Core Viewpoint - Elevance Health, Inc. is under investigation for potential securities fraud and unlawful business practices following a notification from the Centers for Medicare & Medicaid Services regarding sanctions on its Medicare Advantage plans [1][2]. Group 1: Investigation Details - Pomerantz LLP is investigating claims on behalf of Elevance investors, focusing on possible securities fraud or unlawful business practices by the company and its officers [1]. - The investigation was prompted by a recent disclosure from Elevance about sanctions from CMS, which may affect its Medicare Advantage-Prescription Drug plans [2]. Group 2: CMS Sanctions - On March 2, 2026, Elevance announced that CMS intends to impose sanctions that would suspend enrollment of Medicare beneficiaries into its MA-PD plans and halt certain communications with these beneficiaries [2]. - The sanctions are related to alleged noncompliance with Medicare Advantage risk adjustment data submission requirements for services prior to April 3, 2023, and are set to take effect on March 31, 2026, unless resolved [2]. - Following this announcement, Elevance's stock price dropped by $25.93, or 8.1%, closing at $294.07 per share on the same day [2].

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the "company†) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the "Junior Subordinated Notes Offering†). The Junior Subordinated Notes Offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the. ...

Oscar Health, Inc. (OSCR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, OSCR broke out above the 50-day moving average, suggesting a short-term bullish trend.One of the three major moving averages, the 50-day simple moving average is commonly used by traders and analysts to determine support or resistance levels for different types of securities. However, the 50-day is considered to be more important since it's the first marker of ...

Alight and VB Scout expand Voluntary Benefits value through claims integrationMar 5, 2026 8:32 AM Eastern Standard Time# Alight and VB Scout expand Voluntary Benefits value through claims integrationShare---New collaboration brings intelligent claims monitoring technology to Alight's clients and their employees, helping ensure employees capture the full value of their voluntary benefits coverageCHICAGO--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth, ...

Government agencies- Hospitals- Retailers- Drug wholesalersMerck's growth is a result of its efforts and strategic collaborations. The company works with AstraZeneca, Bayer, Eisai, Ridgeback Biotherapeutics, and Gilead Sciences to jointly develop and commercialize long-acting HIV treatments, demonstrating a commitment to innovation and growth.Bank of America currently has a $132.00 price target on this stock.## Public Service EnterpriseOff the radar for many, this dividend-paying utility stock still has roo ...

Key Takeaways CLOV posted 38% Medicare Advantage enrollment growth and earned a 4-Star CMS rating in Q4 2025.Clover delivered $22M adjusted EBITDA in 2025 and guides up to $70M for 2026.Elevated medical costs and Medicare policy shifts may pressure Clover's margins.Clover Health Investments (CLOV) is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This optimism is primarily driven by its technology-first care model, as evident from solid membership growth, rising reven ...

ERLANGER, Ky., March 04, 2026 (GLOBE NEWSWIRE) -- DAV (Disabled American Veterans) has announced its continued partnership with Humana, one of the nation’s leading health and well-being companies. The relationship builds on Humana’s long-standing commitment to supporting veterans and expands its investment in organizations that provide critical programs and services for veterans and their families. Humana works to help people achieve their best health by partnering with communities, veterans service organiz ...

Core Insights - Clover Health is the first payer to implement real-time patient access to claims data on a CMS Aligned Network, showcasing the feasibility of nationwide interoperable data exchange today [1][5]. Group 1: Collaboration and Technology - Clover Health collaborates with Kno2 to enable real-time responses to patient requests for clinical and claims data using standardized FHIR formats [2]. - The infrastructure supporting Clover Health's participation is powered by Counterpart Health, which facilitates the standardized exchange of data across the network [4][6]. Group 2: Patient-Centric Approach - The ability for Medicare patients to access their health information seamlessly across various care settings is crucial for coordinated care, especially for those with multiple chronic conditions [3]. - Real-time access to clinical and claims information enhances transparency and control for members, allowing for easier sharing with caregivers and a better understanding of their health journey [6]. Group 3: Industry Impact and Future Initiatives - Clover Health's early adoption sets a standard for other payers, indicating that interoperable, patient-directed data exchange is achievable [5]. - Live demonstrations of the end-to-end response to patient authenticated claims data requests will take place at HIMSS 2026, highlighting the practical application of this technology [7].